11/14
08:12 am
galt
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update [Yahoo! Finance]
Medium
Report
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update [Yahoo! Finance]
11/14
08:00 am
galt
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update
Medium
Report
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update
11/13
12:08 am
galt
Galectin Therapeutics Inc. (NASDAQ: GALT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Galectin Therapeutics Inc. (NASDAQ: GALT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
10/15
08:00 am
galt
Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
Low
Report
Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
10/15
02:07 am
galt
Galectin Therapeutics Inc. (NASDAQ: GALT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Galectin Therapeutics Inc. (NASDAQ: GALT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
10/6
02:02 am
galt
Galectin Therapeutics Inc. (NASDAQ: GALT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Galectin Therapeutics Inc. (NASDAQ: GALT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
9/30
08:00 am
galt
Galectin Therapeutics to Participate in the H.C. Wainwright MASH Conference
Low
Report
Galectin Therapeutics to Participate in the H.C. Wainwright MASH Conference
9/28
02:02 am
galt
Galectin Therapeutics Inc. (NASDAQ: GALT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Galectin Therapeutics Inc. (NASDAQ: GALT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/14/2024
08:00 am
GALT
galectin therapeutics inc.
BEAT
Report
-7.1%
galectin therapeutics inc.
8/13/2024
08:00 am
GALT
galectin therapeutics inc.
MISS
Report
8.2%
galectin therapeutics inc.
5/15/2024
08:00 am
GALT
galectin therapeutics inc.
MISS
Report
7.7%
galectin therapeutics inc.
11/14
08:01 am
galt
Form 8-K GALECTIN THERAPEUTICS For: Nov 14
Medium
Report
Form 8-K GALECTIN THERAPEUTICS For: Nov 14
11/14
07:56 am
galt
Form 8-K GALECTIN THERAPEUTICS For: Nov 14
Medium
Report
Form 8-K GALECTIN THERAPEUTICS For: Nov 14
11/14
07:51 am
galt
Form 10-Q GALECTIN THERAPEUTICS For: Sep 30
Medium
Report
Form 10-Q GALECTIN THERAPEUTICS For: Sep 30
10/23
01:40 pm
galt
Form 4 GALECTIN THERAPEUTICS For: Oct 23 Filed by: ELDRED KARY
Neutral
Report
Form 4 GALECTIN THERAPEUTICS For: Oct 23 Filed by: ELDRED KARY
10/17
04:04 pm
galt
Form 4 GALECTIN THERAPEUTICS For: Oct 17 Filed by: FREEMAN KEVIN D
Low
Report
Form 4 GALECTIN THERAPEUTICS For: Oct 17 Filed by: FREEMAN KEVIN D
10/16
04:12 pm
galt
Form 4 GALECTIN THERAPEUTICS For: Oct 16 Filed by: FREEMAN KEVIN D
Neutral
Report
Form 4 GALECTIN THERAPEUTICS For: Oct 16 Filed by: FREEMAN KEVIN D
10/4
04:10 pm
galt
Form 144 GALECTIN THERAPEUTICS Filed by: Boudes Pol F
Medium
Report
Form 144 GALECTIN THERAPEUTICS Filed by: Boudes Pol F
9/9
08:01 am
galt
Form 8-K GALECTIN THERAPEUTICS For: Sep 09
Medium
Report
Form 8-K GALECTIN THERAPEUTICS For: Sep 09
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register